Phase II trial of oxaliplatin (L-OHP) in advanced, recurrent and/or metastatic squamous cell carcinoma of the head and neck-Reference-Cited by-同舟云学术

Phase II trial of oxaliplatin (L-OHP) in advanced, recurrent and/or metastatic squamous cell carcinoma of the head and neck

Published:1996-07 Issue:4 Volume:32 Page:278-279
ISSN:0964-1955
Container-title:European Journal of Cancer Part B: Oral Oncology
language:en
Short-container-title:European Journal of Cancer Part B: Oral Oncology

Author:

Degardin M.,Cappelaere P.,Krakowski I.,Fargeot P.,Cupissol D.,Brienza S.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference10 articles.

1. Antitumour activity of L-OHP in mice;Mathe;Cancer Lett,1985

2. Oxalato-platinum or L-OHP, a third generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cisplatinum and carboplatinum;Mathe;Biomed Pharmacother,1989

3. Phase I study of oxaliplatin in patients with advanced cancer;Extra;Cancer Chemother Pharmacol,1990

4. Early phase II trial of trans-I-diammino-cyclohexane oxaloplatin (L-OHP) in malignant melanoma, ovarian carcinoma and non-Hodgkin's lymphoma (NHL);Misset;Eur J Cancer,1991

5. Clinical characteristics and reversibility of neurological signs after long term oxaliplatin (L-OHP) therapy;Brienza;Ann Oncol,1994

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focus on Multi-targeted Role of Curcumin: a Boon in Therapeutic Paradigm;Environmental Science and Pollution Research;2021-02-17

2. Current evidence and future perspectives for curcumin and its analogues as promising adjuncts to oxaliplatin: state-of-the-art;Pharmacological Research;2019-03

3. New bioactive peptide reduces the toxicity of chemotherapy drugs and increases drug sensitivity;Oncology Reports;2017-01

4. Current and Emerging Role of Chemotherapy in Oral Cancer;Contemporary Oral Oncology;2016-12-15

5. Clinical Translation of Nanomedicine;Chemical Reviews;2015-06-19